The infographic includes trend data on:

• The effect of COVID-19 on medical cost trend
• How the cost trend for mental health compares to overall medical cost trend
• How the cost trend for cancer treatment — typically a major driver of costs for most health plans — compares to overall medical cost trend
• The recent acceleration in prescription drug trend that’s mainly attributable to high utilization of glucagon-like peptide-1 receptor agonist (GLP-1) drugs used to treat diabetes and for weight loss

You'll also learn:

• The three main drivers of medical cost trend
• The five conditions that are the main drivers of mental health cost trend
• The five types of cancer that are driving costs related to cancer treatment
• The three other conditions that, in addition to diabetes and obesity, are also major drivers of prescription drug expenses

There's more data in the infographic! You'll get:

• The percent of all mental health-related visits that are done virtually
• The percent of all virtual visits that are related to mental health
• The 78 percent increases in the gross allowed cost per member per month (PMPM) for anti-diabetic GLP-1s (e.g., Mounjaro®, Ozempic® and Rybelus®) between the first quarter of 2022 to the second quarter of 2023
• How the gross allowed cost PMPM for anti-obesity GLP-1s (e.g., Saxenda® and Wegovy®) roughly doubled in each of the first two quarters of 2023